Physiomics to present on R&D Developments at the 2011 EORTC-NCI-AACR symposium on “Molecular targets and Cancer Therapeutics”

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the EORTC-NCI-AACR symposium on “Molecular Targets and Cancer Therapeutics”, taking place at the Moscone Center West, San Francisco, California on 12-16 November 2011. Dr Eric Fernandez, Project Leader at Physiomics, will present on a prototype version of an anti-cancer drug combination and regimen database. Dr Frances Brightman, Senior Scientist at Physiomics, will present on the use of three-dimensional cell cultures to calibrate Virtual TumourTM.

Read more…